Research Topics
| R KahnSummaryAffiliation: American Diabetes Association Country: USA Publications
| Collaborators
|
Detail Information
Publications
Metabolic syndrome: is it a syndrome? Does it matter?Richard Kahn
American Diabetes Association, 1701 N Beauregard St, Alexandria, VA 22311, USA
Circulation 115:1806-10; discussion 1811. 2007- The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of DiabetesR Kahn
American Diabetes Association, 1701 N Beauregard Street, Alexandria, VA 22311, USA
Diabetologia 48:1684-99. 2005..The term 'metabolic syndrome' refers to a clustering of specific cardiovascular disease (CVD) risk factors whose underlying pathophysiology is thought to be related to insulin resistance... - Dealing with complexity in clinical diabetes: the value of archimedesRichard Kahn
Diabetes Care 26:3168-71. 2003 - Metabolic syndrome--what is the clinical usefulness?Richard Kahn
American Diabetes Association, Alexandria, VA 22307, USA
Lancet 371:1892-3. 2008 - The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of DiabetesRichard Kahn
American Diabetes Association, 1701 N Beauregard St, Alexandria, Virginia 22311, USA
Diabetes Care 28:2289-304. 2005..quot; Until much needed research is completed, clinicians should evaluate and treat all CVD risk factors without regard to whether a patient meets the criteria for diagnosis of the "metabolic syndrome.".. - Commentary on the results and clinical implications of the PROactive studyRobert Rizza
American Diabetes Association, 1701 N. Beauregard Street, Alexandria, VA 22311, USA
Diabetes Care 28:2965-7. 2005 
The impact of prevention on reducing the burden of cardiovascular diseaseRichard Kahn
American Diabetes Association, Alexandria, VA, USA
Circulation 118:576-85. 2008..We therefore determined the effects of 11 nationally recommended prevention activities on CVD-related morbidity, mortality, and costs in the United States...
The impact of prevention on reducing the burden of cardiovascular diseaseRichard Kahn
American Diabetes Association, Alexandria, Virginia, USA
Diabetes Care 31:1686-96. 2008..We therefore determined the effects of 11 nationally recommended prevention activities on CVD-related morbidity, mortality, and costs in the U.S...- Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart AssociationRobert H Eckel
Department of Physiology and Biophysics, University of Colorado Health Science Center, Aurora, USA
Diabetes Care 29:1697-9. 2006 - Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart AssociationHarmon Eyre
Stroke 35:1999-2010. 2004.... - Preventing cancer, cardiovascular disease, and diabetes: a common agenda for theAmerican Cancer Society, the American Diabetes Association, and the American Heart AssociationHarmon Eyre
Nutrition and Physical Activity, American Cancer Society, Atlanta, GA, USA
CA Cancer J Clin 54:190-207. 2004.... - Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetesDavid M Eddy
Archimedes Project, Kaiser Permanente, Oakland, California, USA
Ann Intern Med 143:251-64. 2005..Lifestyle modification can forestall diabetes in high-risk people, but the long-term cost-effectiveness is uncertain... - Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes AssociatSamuel Klein
Center for Human Nutrition and the Division of Geriatrics and Nutritional Science, Washington University School of Medicine, St Louis, MO 63110, USA
Am J Clin Nutr 85:1197-202. 2007 - Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart AssociationHarmon Eyre
Circulation 109:3244-55. 2004.... - Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003Richard W Nesto
Circulation 108:2941-8. 2003 - Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart AssociationRobert H Eckel
Circulation 113:2943-6. 2006 - Waist Circumference and Cardiometabolic Risk: a Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes AssociatSamuel Klein
Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8031, Saint Louis, Missouri 63110, USA
Obesity (Silver Spring) 15:1061-7. 2007 - Cure, care, and commitment: what can we look forward to?Robert Rizza
Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA
Diabetes Care 31:1051-9. 2008 - Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes AssociatSamuel Klein
Division of Geriatrics and Nutritional Science, Center for Human Nutrition, Washington University School of Medicine, St. Louis, Missouri 63110, USA
Diabetes Care 30:1647-52. 2007 - A step backward--or is it forward?Saul Genuth
Division of Clinical and Molecular Endocrinology, Department of Medicine, Case Western Reserve University, Cleveland, Ohio 44106 4951, USA
Diabetes Care 31:1093-6. 2008 - Validation of prediction of diabetes by the Archimedes model and comparison with other predicting modelsMichael Stern
Division of Clinical Epidemiology, University of Texas Health Science Center, San Antonio, Texas, USA
Diabetes Care 31:1670-1. 2008..To validate the ability of the Archimedes model to accurately predict the risk of developing diabetes in individuals... - Translating the A1C AssayRichard Kahn
Diabetes Care 31:1704-7. 2008 - The metabolic syndromeRichard Kahn
Lancet 366:1921-2; author reply 1923-4. 2005 - Prolonged bottle use and its association with iron deficiency anemia and overweight: a preliminary studyKaren A Bonuck
Clin Pediatr (Phila) 41:603-7. 2002..Daily bottle use ranged from 3 to 10 (mean=3.3, median=3). Bottle use was significantly associated with obesity (>95th% BMI, p<0.0005), not significant with overweight (>85th% BMI, p<0.06) and statistically significant with IDA... - Implications of the United kingdom prospective diabetes studySaul Genuth
Diabetes Care 26:S28-32. 2003 - The prevention or delay of type 2 diabetesRobert S Sherwin
Diabetes Care 26:S62-9. 2003 - A model to determine workforce needs for endocrinologists in the United States until 2020Robert A Rizza
Division of Endocrinology, Metabolism, Nutrition, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
J Clin Endocrinol Metab 88:1979-87. 2003.... - A model to determine workforce needs for endocrinologists in the United States until 2020Robert A Rizza
Division of Endocrinology, Metabolism, Nutrition, and Internal Medicine, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN, USA
Endocr Pract 9:210-9. 2003.... - Follow-up report on the diagnosis of diabetes mellitusSaul Genuth
Diabetes Care 26:3160-7. 2003 - Prevention or delay of type 2 diabetesRobert S Sherwin
Diabetes Care 27:S47-54. 2004 - Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes AssociationRichard W Nesto
American Diabetes Association
Diabetes Care 27:256-63. 2004 - Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart AssociationHarmon Eyre
Diabetes Care 27:1812-24. 2004.... - Is late bottle-weaning associated with overweight in young children? Analysis of NHANES III dataKaren Bonuck
Department of Epidemiology and Population Health, Montefiore Medical Center Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA
Clin Pediatr (Phila) 43:535-40. 2004..0099-0.0535). Prolonged bottle use in young children is associated with increased risk of overweight. From a preventive medicine standpoint, decreasing exposure to this potential risk for childhood overweight is indicated... - Profiling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment resultsSheldon Greenfield
Primary Care Outcomes Research Institute, Tufts University School of Medicine, M and V 1, 136 Harrison Avenue, Boston, MA 02111, USA
Ann Intern Med 136:111-21. 2002..Patient characteristics (case-mix bias) and physician-level variation (clustering) are often overlooked in profiling the quality of care provided by different groups of physicians, such as specialties... - A 4-year trial of tiotropium in chronic obstructive pulmonary diseaseDonald P Tashkin
David Geffen School of Medicine at the University of California, Los Angeles 90095 1690, USA
N Engl J Med 359:1543-54. 2008..Previous studies showing that tiotropium improves multiple end points in patients with chronic obstructive pulmonary disease (COPD) led us to examine the long-term effects of tiotropium therapy...